11 February 2022
Carl Zeiss Meditec generated revenue of €410.2m in the first three months of fiscal year 2021/22 (prior year: €368.9m), corresponding to an increase of 11.2% (adjusted for currency effects: +10.5%) compared with the same period of the prior year.
31 January 2021
The new Sustainability Report for fiscal year 2020/21 demonstrates how ZEISS is taking responsibility throughout the value chain and has positioned itself as future-ready in order to overcome the challenges ahead.
16 December 2021
The Carl Zeiss AG shareholders' meeting has appointed Dr. Michael Bolle the new Supervisory Board member to represent the sole shareholder the Carl Zeiss Foundation. He will be elected Chairman of the Supervisory Board of Carl Zeiss AG in January 2022.